PRKACB and non-small cell lung carcinoma: PRKACB mutations and gene fusion of PRKACB can lead to adrenal, bile duct, liver, and pancreatic cancers 12,13, meanwhile down-regulation of PRKACB expression may be associated with poor survival in patients with non-small cell lung cancer.